Wednesday, January 12, 2022

Addressing racial bias in treating sickle cell disease

Addressing racial bias in treating sickle cell disease

Sickle cell disease is just one of the conditions that disproportionately impact underserved minority communities. CVS Caremark® aims to help sickle cell patients access appropriate medications and increase genetic trait testing. Their plans include working with community partners to increase awareness about HIV testing and prevention, and helping more people receive appropriate medication for cardiovascular disease.

Read more about health inequities


No comments:

Post a Comment